Le Lézard
Classified in: Health, Science and technology
Subjects: CSR, MAT

How Holiday Sales Can Help: FAB CBD's Biggest Discounts and Donations


The season of gratitude and gift shopping translates into increased charitable giving at FAB CBD.

MILWAUKEE, Nov. 4, 2022 /PRNewswire/ -- As FAB's Black Friday/Cyber Monday sale kicks off today, customers are saving up to 50% off everything, and they are supporting a very worthy cause while they do their holiday shopping. Last year FAB CBD donated $15,000 to Charlie Rocket's Dream Machine because they believe in helping out real people with specific needs and dreams. Founder Josh Delaney felt so moved by their mission and having boots on the ground, he matched FAB's donation with an additional $15,000 making it $30,000 total to help families affected by natural disaster.

FAB CBD kicks off its biggest sale event of the year with up to 50% off sitewide, now through November 30th.

FAB CBD is joining forces once again with Charlie Rocket's Dream Machine Tour to help children with cancer. Their end goal is to raise $1 million, with a preliminary goal of $500,000. During the 4th quarter, FAB will be donating a portion of all sale purchases to this cause. So while customers shop with the highest discounts of the year, they will also be contributing to those in need.

The Black Friday and Cyber Monday Sales have turned into an almost month-long event, lasting from November 3 - November 30th and offering up to 50% sitewide. Some of the hottest items include the new Complete Cannabinoid Soft Gels and the ever-popular Nighttime Gummies, among staples like full spectrum CBD Oil and CBD Body Salve. While you do your holiday shopping, you can feel good about being part of an effort to support those in need and spread a little good will.

Shop The Black Friday Sale - Up to 50% Off Storewide.

FAB CBD is best known for its highly-rated CBD products that include a line of organic full spectrum oils in varying strengths and flavors, Anytime and Sleep CBD Gummies, CBD Topical Cream, CBD Body Salve, CBD Dog Treats, CBD+CBG full spectrum oil, and the brand's latest offering of Complete Cannabinoid Soft Gels.

Shop The Sale Until November 30th By Going To: https://fabcbd.com/

SOURCE FAB CBD


These press releases may also interest you

at 01:15
Genentech Provides Update on Phase II/III SKYSCRAPER-06 Study in Metastatic Non-Squamous Non-Small Cell Lung Cancer
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI: Appointment of Adviser
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
If You Purchased, Paid, or Provided Reimbursement for Some or All of the Price of Branded Lipitor® or its Generic Equivalent, Atorvastatin Calcium, You Could Get Money From a Settlement
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

3 jui 2024
LOTTE BIOLOGICS Holds Groundbreaking for Songdo Bio Campus
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

3 jui 2024
Ascentage Pharma Received US$100 Million Option Payment from Takeda
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

3 jui 2024
Atara Biotherapeutics To Participate at the Stifel Virtual Cell Therapy Forum
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...

More news about Health...


News published on and distributed by: